Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
Ju
O
O
Department of Microbiology and Infectious Diseases, Flinders Medical Centre and Flinders University, Bedford Park, 5042 South Australia, Australia.
Woolley
M
M
Gordon
D
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology* / Q000635:transmission; D004359:Drug Therapy, Combination; D005838:Genotype; D006801:Humans; D007362:Intensive Care Units; D016106:Methicillin Resistance / Q000187:drug effects; D016133:Polymerase Chain Reaction / Q000379:methods; D012150:Polymorphism, Restriction Fragment Length; D012189:Retrospective Studies; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000635:transmission; D013211:Staphylococcus aureus / Q000145:classification / Q000187:drug effects* / Q000472:pathogenicity; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D012293:Rifampin